How AstraZeneca’s 17,000 AI-certified employees are helping it reach a ‘stretch goal’ of $80 billion in revenue
AstraZeneca has certified over 17,000 employees in AI competencies as part of a broader strategy to support its ambitious $80 billion revenue target by 2030, with finance playing a key role in prioritizing scalable AI pilots. The company is advancing its goals through existing products, new indications, and the development of new molecular entities, while navigating challenges like patent expirations and market access. Despite macroeconomic and geopolitical uncertainties, AstraZeneca continues to invest heavily in R&D and AI infrastructure to drive growth and operational transformation.
Opening excerpt (first ~120 words) tap to expand
Good morning. AstraZeneca’s AI strategy has moved well past the exploration phase as upskilling employees became a priority.Recommended Video The biopharmaceutical giant has now certified more than 17,000 of its employees in AI competencies, Aradhana Sarin, CFO of AstraZeneca, told me. The program mandates that all staff above a certain grade reach at least a silver-level certification across a Bronze-Silver-Gold framework. Sarin described initial hesitancy giving way to genuine enthusiasm as employees saw the executive team’s commitment reflected in real investment. “I think people are really embracing AI and learning and developing their own skills,” Sarin said. Where Sarin sees finance playing an immediate and critical role is in prioritization.
…
Excerpt limited to ~120 words for fair-use compliance. The full article is at Fortune.
Discussion
0 commentsMore from Fortune
